
Diabetes is a global epidemic that has enormous health, social, and economic implications. Because the urgency of early diabetes detection is critical in helping stem this epidemic, VeraLight has developed the SCOUT DS® system. The SCOUT DS® system is the first noninvasive diabetes screening system designed to provide an accurate and convenient method for screening type 2 diabetes, and pre-diabetes based on the presence of advanced glycation endproducts (AGEs) biomarkers found in skin. Unlike current screening methods, a SCOUT DS® test does not require a blood draw, no fasting and no waiting for a lab result.
| Manufacturer: Veralight Inc | |
Download White Paper |
|